Cytokine storm and probable role of immunoregulatory drugs in COVID-19: a comprehensive review

A Sadeghzadeh-Bazargan, E Behrangi… - Iranian Journal of …, 2020 - iranjd.ir
The coronavirus disease 2019 (COVID-19) is currently the most important global health
problem. Due to its pandemic state and high mortality rate, it is critical to find useful …

Use of immunosuppressants/immunomodulators in autoimmune/inflammatory dermatologic diseases during COVID-19 pandemic—General recommendation based …

D De, D Pandhi - Indian Dermatology Online Journal, 2020 - journals.lww.com
angiotensin‑converting enzyme (ACE) 2 gene that encodes the attachment receptor for
SARS‑CoV‑2, is demethylated and overexpressed in active lupus patients. Therefore, a …

Cutaneous manifestations and considerations in COVID‐19 pandemic: a systematic review

F Seirafianpour, S Sodagar… - Dermatologic …, 2020 - Wiley Online Library
COVID‐19 had a great impact on medical approaches among dermatologist. This systematic
review focuses on all skin problems related to COVID‐19, including primary and secondary …

Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?

M Komine, TM Ansary, MR Hossain, K Kamiya… - International Journal of …, 2022 - mdpi.com
COVID-19 is a recently emerged viral infection worldwide. SARS-CoV-2, the causative virus,
is believed to have emerged from bat coronaviruses, probably through host conversion. The …

Utility and risk of dermatologic medications during the COVID‐19 pandemic

M Goldust, K Hartmann, A Abdelmaksoud… - Dermatologic …, 2020 - Wiley Online Library
In the era of staggering speed in development of the novel coronavirus disease (COVID‐19)
pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), we …

Managing cutaneous immune-mediated diseases during the COVID-19 pandemic

T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

M Soy, G Keser, P Atagündüz, F Tabak… - Clinical …, 2020 - Springer
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

COVID‐19 and immunosuppressive therapy in dermatology

RA Schwartz, S Pradhan, DF Murrell… - Dermatologic …, 2020 - Wiley Online Library
Abstract Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has
become a pandemic. With concern about therapies that may decrease immunity and …

Coronavirus disease (COVID‐19): An updated review based on current knowledge and existing literature for dermatologists

I Kaur, A Sharma, D Jakhar, A Das… - Dermatologic …, 2020 - Wiley Online Library
The world entered the year 2020 with reports of the emergence of a new viral illness in
Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome …

Pathogenesis and treatment of cytokine storm in COVID-19

M Soy, G Keser, MP Atagündüz - Turkish Journal of Biology, 2021 - journals.tubitak.gov.tr
COVID-19 is a viral infection caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that killed a large number of patients around the world. A hyperinflammatory …